Prenatal exposure to valproate was linked to increased odds of babies developing spina bifida and hypospadias, but researchers found that lowering the dose of the medication in the first trimester could control women's epileptic seizures without raising their child's risk of having the defects. The findings appear in the journal American Academy of Neurology.
Lowered valproate doses during pregnancy may curb birth defect risks
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|